Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)

PHASE3CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

September 30, 2008

Conditions
Asthma
Interventions
DRUG

Ciclesonide

inhaled Ciclesonide 160 µg, once daily in the morning

DRUG

Fluticasone

inhaled Fluticasone 100 µg, twice daily

Trial Locations (1)

9700

Altana Pharma/Nycomed, RB Groningen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY